Higher incidence of diabetes in cancer patients compared to cancer-free population controls: a systematic review and meta-analysis

K Yang, Z Liu, MSY Thong, D Doege, V Arndt - Cancers, 2022 - mdpi.com
Simple Summary Diabetes increases the risk of certain types of cancer. However, the
literature regarding the incidence of diabetes after cancer diagnosis is inconsistent. We …

Cardiovascular disease risk among cancer survivors: the atherosclerosis risk in communities (ARIC) study

R Florido, NR Daya, CE Ndumele, S Koton… - Journal of the American …, 2022 - jacc.org
Background More than 80% of adult patients diagnosed with cancer survive long term. Long-
term complications of cancer and its therapies may increase the risk of cardiovascular …

Diabetes and colorectal cancer risk: a new look at molecular mechanisms and potential role of novel antidiabetic agents

J Vekic, A Zeljkovic, A Stefanovic, RV Giglio… - International Journal of …, 2021 - mdpi.com
Epidemiological data have demonstrated a significant association between the presence of
type 2 diabetes mellitus (T2DM) and the development of colorectal cancer (CRC). Chronic …

The prognostic outcome of 'type 2 diabetes mellitus and breast cancer'association pivots on hypoxia-hyperglycemia axis

IA Durrani, A Bhatti, P John - Cancer cell international, 2021 - Springer
Type 2 diabetes mellitus and breast cancer are complex, chronic, heterogeneous, and multi-
factorial diseases; with common risk factors including but not limited to diet, obesity, and …

Roles of interstitial fluid pH and weak organic acids in development and amelioration of insulin resistance

Y Marunaka - Biochemical Society Transactions, 2021 - portlandpress.com
Type 2 diabetes mellitus (T2DM) is one of the most common lifestyle-related diseases
(metabolic disorders) due to hyperphagia and/or hypokinesia. Hyperglycemia is the most …

Repurposing metabolic regulators: Antidiabetic drugs as anticancer agents

Y Dhas, N Biswas, D MR, LD Jones, S Ashili - Molecular Biomedicine, 2024 - Springer
Drug repurposing in cancer taps into the capabilities of existing drugs, initially designed for
other ailments, as potential cancer treatments. It offers several advantages over traditional …

Diabetes and cancer: Optimising glycaemic control

N Joharatnam‐Hogan… - Journal of Human …, 2023 - Wiley Online Library
Diabetes and cancer are both common and increasingly prevalent conditions, but emerging
epidemiological evidence confirms that the risk of developing a number of common cancers …

The dichloromethane fraction from Calotropis gigantea (L.) dryand. Stem bark extract prevents liver cancer in SDT rats with insulin-independent diabetes mellitus

T Haewphet, S Parhira, P Chaisupasakul… - Journal of …, 2024 - Elsevier
Ethnopharmacological relevance Calotropis gigantea (L.) Dryand.(C. gigantea) is a
traditional medicinal plant, recognized for its effectiveness in managing diabetes, along with …

The impact of surgery and oncological treatment on risk of type 2 diabetes onset in patients with colorectal cancer: nationwide cohort study in Denmark

C Krag, MS Svane, S Madsbad, SB Graversen… - Elife, 2024 - elifesciences.org
Background: Comorbidity with type 2 diabetes (T2D) results in worsening of cancer-specific
and overall prognosis in colorectal cancer (CRC) patients. The treatment of CRC per se may …

Colorectal Cancer and Subsequent Diabetes Risk: A Population-Based Cohort Study in Taiwan

HY Hsu, YJ Chern, MS Hsu, TL Yeh… - The Journal of …, 2024 - academic.oup.com
Context The association between colorectal cancer (CRC) and new-onset diabetes mellitus
remains unclear. Objective To examine the association between CRC and the risk of …